Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2017 Publisher: Bayer New Zealand Limited, 3 Argus Place, Hillcrest, North Shore, Auckland 0627, P. O. Box 2825, Shortland Street, Auckland 1140, Freephone 0800 229 379
Polaramine is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild uncomplicated allergic skin manifestations of urticaria and angioedema. Polaramine may relieve itching due to skin conditions such as allergic eczema, pruritus ani, pruritus vulvae, atopic dermatitis, contact dermatitis, insect bites, dermographism and medicine reactions, including serum sickness.
Adults and children over 12 years: One tablet every 6 hours.
Adults and children over 12 years: 5 mL every 6 hours.
Children 6-12 years: 2-4 mL every 6-8 hours.
Children 4 – 6 years: 1.75-2 mL every 6-8 hours.
Children 2-4 years: 1.25-1.75 mL every 6-8 hours.
Polaramine Syrup is not to be used in children under 2 years of age.
Polaramine Syrup can be used for children from 2 years of age.
Dosages are:
Children over 12 years: 5 mL every 6 hours.
Children 6-12 years: 2-4 mL every 6-8 hours.
Children 4 – 6 years: 1.75-2 mL every 6-8 hours.
Children 2-4 years: 1.25-1.75 mL every 6-8 hours.
Antihistamine overdosage effects may vary from central nervous system depression (apnoea, arrhythmias, cardiovascular collapse, cyanosis, diminished mental alertness, sedation) to stimulation (convulsions, hallucinations, insomnia or tremors) to death. Other signs and symptoms may be ataxia, blurred vision, dizziness, hypotension and tinnitus. Stimulation is particularly likely in children, as are atropine-like signs and symptoms (dry mouth; fixed, dilated pupils; flushing; gastrointestinal symptoms and hyperthermia).
Dialysis is of little value in antihistamine poisoning. Treatment of the signs and symptoms of an over dosage are symptomatic and supportive. Consider standard measures to remove any unabsorbed medicine. There is no specific antidote. Measures to enhance excretion (urinary acidification, haemodialysis) are not recommended.
Polaramine Tablets: 36 months (3 years) from date of manufacture.
Polaramine Syrup: 36 months (3 years) from date of manufacture.
Tablets: Store at or below 25°C.
Syrup: Store at or below 25°C.
Polaramine Tablets: Available in blister packs of 20 and 40 tablets.
Polaramine Syrup: Available in a glass bottle of 100 mL.
Medicines should not be disposed of via wastewater or household waste. Ask a pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
